Sunil Iyengar

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

Sandy Amorim, Anastasios Stathis, Mary Gleeson et al. · The Lancet Haematology · 2016 · 420 citations

Hematological Malignancy, Lymphoid Neoplasia, Translational Medicine +9

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 271 citations · Full text

To read or not to read: A question of national consequence

Sunil Iyengar · 2007 · 221 citations

Public Policy, National Consequence, Civil Liberty +9

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au et al. · Nature Cancer · 2021 · 177 citations · Full text

Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study

Roger G. Owen, Helen O. McCarthy, Simon Rule et al. · The Lancet Haematology · 2019 · 156 citations · Full text

Acalabrutinib Monotherapy, Waldenström Macroglobulinemia, Phase 2 +2